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Abstract
Background: MicroRNAs (miRNAs) are small non-coding RNAs that regulate complex transcriptional networks underpin
immune responses. However, little is known about the specific miRNA networks that control differentiation of specific
leukocyte subsets. In this study, we profiled miRNA expression during differentiation of eosinophils from bone marrow (BM)
progenitors (bmEos), and correlated expression with potential mRNA targets involved in crucial regulatory functions.
Profiling was performed on whole BM cultures to document the dynamic changes in miRNA expression in the BM
microenvironment over the differentiation period. miRNA for network analysis were identified in BM cultures enriched in
differentiating eosinophils, and chosen for their potential ability to target mRNA of factors that are known to play critical
roles in eosinophil differentiation pathways or cell identify.
Methodology/Principal Findings: We identified 68 miRNAs with expression patterns that were up- or down- regulated 5-
fold or more during bmEos differentiation. By employing TargetScan and MeSH databases, we identified 348 transcripts
involved in 30 canonical pathways as potentially regulated by these miRNAs. Furthermore, by applying miRanda and
Ingenuity Pathways Analysis (IPA), we identified 13 specific miRNAs that are temporally associated with the expression of IL-
5Ra and CCR3 and 14 miRNAs associated with the transcription factors GATA-1/2, PU.1 and C/EBPe. We have also identified
17 miRNAs that may regulate the expression of TLRs 4 and 13 during eosinophil differentiation, although we could identify
no miRNAs targeting the prominent secretory effector, eosinophil major basic protein.
Conclusions/Significance: This is the first study to map changes in miRNA expression in whole BM cultures during the
differentiation of eosinophils, and to predict functional links between miRNAs and their target mRNAs for the regulation of
eosinophilopoiesis. Our findings provide an important resource that will promote the platform for further understanding of
the role of these non-coding RNAs in the regulation of eosinophil differentiation and function.
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Introduction
Eosinophils are multifunctional granulocytes that are capable of
synthesising a wide range of proinflammatory mediators [1] and
are implicated in the pathogenesis of a substantial array of allergic
disorders [2]. Likewise, conditions of dysregulated eosinophil
growth and differentiation include complex disorders such as
hypereosinophilic syndromes and eosinophilic leukaemia [3]. As
such, studies that promote insight into pathways controlling
eosinophil differentiation are central to understanding how these
cells develop and their roles in health and disease.
Eosinophil differentiation and function is mediated by cell
surface receptors that promote growth, adhesion, chemotaxis,
degranulation and cell-to-cell communication [2,4–6]. Although
many factors contribute to the development of eosinophils,
interleukin (IL) -5 plays a unique and profound role in driving
differentiation and mobilisation from the bone marrow and in
sustaining viability in the periphery. Likewise, eotaxins are ligands
for cell surface CC-chemokine receptor 3 (CCR3), and serve to
modulate eosinophil homing and accumulation in tissues both
cooperatively with IL-5 and via IL-5-independent pathways [7,8].
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In this regard, IL-5 receptor subunit–a chain (IL-5Ra) and CCR3
play pivotal roles in orchestrating eosinophil activation, growth,
differentiation and chemotaxis [2,7,9–12]. Indeed, mice deficient
in IL-5, eotaxin or their respective receptors have significantly
diminished numbers of eosinophils in tissues in response to
inflammatory stimuli [13–16]. Furthermore, humanized antibod-
ies against IL-5 (e.g. mepolizumab and reslizumab) and IL-5Ra
(e.g. benralizumab) have been shown clinically to reduce
circulating eosinophil numbers and/or to suppress eosinophil
maturation in the bone marrow [17–19].
GATA family transcription factors (GATA) -1 and -2 have
been implicated in driving eosinophil lineage commitment and
differentiation [20]. Several lines of evidence have implicated
specifically GATA-1 in guiding eosinophil development [20–23].
However, substantial evidence suggests that the interplay of
several key transcription factors, including GATA -1 and -2,
PU.1 and CCAAT/enhancer binding proteins (c/EBPs), pro-
vides unique instructive signals for the commitment and
maturation of the eosinophil lineage [24–26]. Interestingly, c/
EBPe in mouse is indispensible for terminal granulopoiesis as
targeted disruption of this gene leads to failure to generate both
neutrophil and eosinophil lineages [27]. However, both activator
and repressor isoforms of c/EBPe in humans may specifically
instruct the development of eosinophil progenitor cells into
mature eosinophils [24]. Most recently, a unique role for the
endoplasmic reticulum stress signaling protein, X-box protein 1
(XBP1), in promoting eosinophil lineage commitment, has been
elucidated [28]. Other intracellular signaling events such as
signal transduction and transcription (STAT) proteins and
epigenetic regulators may also contribute to the differentiation
program [29,30].
MicroRNAs (miRNA) are approximately 22 nucleotides in
length and regulate gene expression by binding to the 39
untranslated regions of their target mRNAs to repress protein
production or destabilise the target transcript [31]. The impor-
tance of miRNAs in modulating cellular function of eukaryotes
(e.g. differentiation, proliferation, metabolism and apoptosis) has
been established [32–34]. The role of miRNA in regulating the
development of immune cells and controlling effective immunity is
also rapidly emerging [32]. However, much less is known about
the miRNA networks that control the differentiation and function
of specific leukocyte subsets. Recently, miRNA have been
implicated in the differentiation and control of eosinophilia in
allergic inflammation, however, a detailed investigation of miRNA
expression patterns employed during differentiation has not yet
been performed [35–37]. The aim of our study is to explore
miRNA expression profiling and analysis in silico in order to
improve our understanding of the factors and circuits that are
involved in the regulation eosinophil growth and differentiation.
As a first approach, we have performed microarrays on whole
bone marrow cultures during eosinophil differentiation to char-
acterise the dynamics of miRNA expression in this cellular milieu.
To predict functional links between miRNAs and their target
mRNAs for the regulation of eosinophil differentiation, we have
examined the expression profiles of miRNA in BM cultures
enriched in differentiating eosinophils, which target seed sequenc-
es in critical factors known to regulate eosinophil differentiation
and cell identity. Our investigation provides novel information on
the miRNA expression patterns during eosinophil differentiation
and as such demonstrates how specific miRNA may contribute to
eosinophil identity and function.
Materials and Methods
Animals
Specific pathogen-free BALB/c mice (6–8 weeks) were obtained
from the animal services unit of the University of Newcastle. All
experiments were performed with approval from the Animal
Ethics Committee of the University of Newcastle (Permit Number:
A-2010-136). All surgery was performed under sodium pentobar-
bital anesthesia, and all efforts were made to minimize suffering.
Culture and Identification of Bone Marrow-derived
Eosinophils
Bone marrow-derived eosinophils (bmEos) were differentiated
and examined as previously described [21]. Briefly, mouse femurs
were flushed with 5 ml ice-cold Hank’s buffered saline (HBSS)
through a 70 mm cell strainer. After lysis of red blood cells and
washing with phosphate buffered saline (PBS) bone marrow cells
were cultured at a concentration of 16106 cells/ml in RPMI-1640
medium (Invitrogen) containing 20% fetal calf serum (FCS), 4 mM
glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin, 25 mM
hydroxyethyl piperazineethanesulfonic acid, 50 mM 2-mercapto-
ethanol, 1x non-essential amino acids and 1 mM sodium pyruvate.
Culture medium was supplemented with 100 ng/ml stem-cell
factor (SCF; PeproTech) and 100 ng/ml FLT3-Ligand (Flt3L;
PeproTech) at 37uC in a humidified atmosphere of 5% CO2 and
95% air. On day 4, the media containing SCF and Flt3L was
replaced with media supplemented with 10 ng/ml recombinant
mouse IL-5 (R&D Systems). Then, every second day from day 4,
one half of the media was replaced with fresh media containing IL-
5 and the cell concentration was maintained at 16106 cells/ml.
Cells were collected every second day for miRNA microarray and
qPCR. The purity of bmEos was determined using flow cytometry
and Giemsa staining.
Giemsa Staining
56105 bmEos were centrifuged in 100 ml aliquots onto clean
glass slides for 5 min at 3006 g using a Cytospin centrifuge.
Cytospin preparations were air dried and fixed followed by
staining with Giemsa. Eosinophils were determined morphologi-
cally as previously described [21,35].
Flow Cytometry
Cells (36105) were incubated first with mouse FcBlock (2.4G2;
BD PharMingen, San Diego, CA, USA) to inhibit nonspecific
binding of antibodies. After washing, cells were stained with anti-
Siglec F, anti-Gr-1, anti-CD11b, anti-CD11c and respective
isotype controls (BD Biosciences, PharMingen). Numbers of
positive cells were quantified by flow cytometry (FACSCanto flow
cytometer, BD Biosciences, San Jose, CA). Eosinophils were
identified as SiglecF+Gr-1+CD11b+CD11c- [21,38]. Data were
collected on a FACSCanto flow cytometer and analysed with
FlowJo software (version 10, Tree Star, Inc).
miRNA Microarray
Total RNA was extracted from bone marrow cells and bmEos
using TRIzol reagents (Life Technologies) and miRNA microarray
was performed as previously reported [35]. Briefly, the Agilent
spike-In control was added to 100 ng RNA, which was dephos-
phorylated by incubating the samples at 37uC for 30 minutes
followed by ligation of Cy3 using the Complete Labelling and
Hybridisation c-Kit (Agilent). Following ligation and drying, the
Cy3-labelled RNA samples were hybridized for 20 h at 55uC to
Agilent 8615K mouse microRNA array slides (AMADID 21828),
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which included 627 mouse miRNA and 39 mouse viral miRNA
from the Sanger database 12.0. After washing with Agilent gene
expression wash buffers, the hybridized microarrays were scanned
on a High Resolution C scanner (Agilent). Data were extracted
from scanned microarrays using Feature Extraction software
(version 10.7.3.1). The fluorescence index of each miRNA at
different timepoints was further normalized to that of the
respective miRNAs in control group (isolated bone marrow cells).
The normalized microarray data were managed and analyzed by
GeneSpring (Agilent). MicroArray data have been deposited into
ArrayExpress (http://www.ebi.ac.uk/arrayexpress/). The acces-
sion number is E-MTAB-2442.
miRNA Quantitative Polymerase Chain Reaction
miRNA quantitative polymerase chain reactions (qPCR) were
performed using the TaqMan MicroRNA reverse transcription kit
(Life Technologies), Taqman MicroRNA qPCR assays (Life
Technologies) and TaqMan Universal PCR Master Mix, as
previously described [35]. qPCR reactions were performed
according to the manufacturers’ suggested conditions. Sno202
was used as a housekeeping control RNA in the experiments.
Relative expression was calculated using the 22DDCt method.
miRNA Target Analysis
For prediction of target genes of differentially expressed
miRNAs, we first used TargetScan 6.1 (http://www.targetscan.
org/) to identify the potential mRNA targets. MeSH database
(http://www.nlm.nih.gov/mesh/meshhome.html) was then em-
ployed to identify the molecules relevant to eosinophil biology by
exact syntax matching. MiRanda (http://www.microrna.org/)
was also used to refine the predicted targets. Ingenuity Pathways
Analysis (Ingenuity Systems, Redwood City, CA) software was
further used to identify canonical signaling pathways containing
the miRNA-associated eosinophil-associated molecules, and to
establish network connections between miRNAs and their
respective predicted targets.
mRNA Quantitative PCR
The method for qPCR has been described in detail elsewhere
[9,23]. Briefly, total RNA was isolated from bone marrow cells
and bmEos from week 2 to week 6 with TriReagent (Life
Technologies), and reverse-transcribed using M-MLV Reverse
Transcriptase (Life Technologies). qPCR was performed using an
ABI Viia7 qpcr machine (Life Technologies). Amplicons were
detected using SYBR green and expression was normalized to
hypoxanthine-guanine phosphoribosyl transferase (HPRT). Prim-
ers sequences are shown in Table S1.
Statistical Analysis
An initial one-way ANOVA was followed by appropriate
comparisons to test for differences between means of groups.
Values are reported as the means 6 SEM for each experimental
group. The number of samples at each time-point ranged from 4
to 6. Differences in means were considered significant if p was ,
0.05. For regression analyses, significance was determined by using
Pearson correlation tests. Pearson statistics are reported in Table
S8 in File S1.
Results
Generation of bmEos
Isolated bone marrow cells from mice were cultured for 14 days
as described in Methods. On day 4, before the addition of IL-5,
and on day 8 and 14 in the presence of IL-5, the percentage of
bmEos was first determined by FACS; the characteristic morpho-
logical features of bmEos, including bilobed nucleus and red-
staining cytoplasmic granules, were identified by Giemsa staining.
The percentage of bmEos (SiglecF+Gr-12CD11b+CD11c2) in-
creased from 2.8% on day 4 to 98.0% by day 14 (Fig. 1A). These
percentages were also observed with Giemsa staining of cytospin
preparations (Fig. 1B and C). The eosinophil population
underwent significant expansion after day 8 in culture. The
numbers of bmEos were increased approximately 320-fold from
0.560.46104 cells/ml at day 4 to 139.0622.06104 cells/ml on
day 14 (Fig. 1C).
Distinct miRNA Expression Profile during Eosinophil
Development
Given the broad involvement of miRNAs in the regulation of
post-transcriptional gene expression, we next determined the
miRNA profile of bmEos from day 4 to day 14. Total RNA was
isolated from cells sampled every second day and screened as
described in Methods. A total of 68 unique miRNAs were selected
based on 5-fold increased or decreased expression during bmEos
differentiation. Among them, 42 exhibited decreased and 26
exhibited increased expression, respectively (Fig. 2). Detailed
information describing these miRNAs is included in Table S2 in
File S1. We confirmed the differential expression of 7 of the 68
miRNAs with qPCR (Fig. 3). These specific miRNAs have been
linked to leukocyte development and inflammation [39–45]. We
also examined the expression levels of miR-223, which has been
reported to be a critical regulator of myeloid development [46].;
interestingly, levels of this miRNA remained largely unchanged
over the differentiation period.
Critical Transcriptional Regulators for Eosinophilopoiesis
are Targeted by Distinct Sets of miRNAs
The differentiation of eosinophils is critically determined by a
coordinated interaction between GATA -1/2, PU.1 and c/EBPe
[25]. Thus, we evaluated the expression levels of these factors by
qPCR and correlated these levels to those of the 68 differentially
expressed miRNAs (Fig. 2). As anticipated, the expression levels of
the four transcription factors were significantly enhanced (Fig. 4A),
as previously reported, during differentiation [22,23,25,47]. With
IPA software and the miRanda database, we identified 14
miRNAs that may have an impact on the expression of these
four crucial transcriptional regulators (Fig. 4B). We correlated the
expression levels of these miRNAs to GATA1 (let-7e, miR -200a, -
378 and -429), GATA2 (miR -132, -144, -193b, -200a, -363 and -
429), PU.1 (miR -7b, -155, -429 and -669f) and c/EBPe (miR -
130a, -152 and -194) (Fig. 4C). Both miR-200a and miR-429 are
linked to GATA -1 and -2; miR-429 is particularly notable, as it
also linked to expression of a third transcription factor, PU.1. The
39-UTR binding sites of miRNAs that target these mRNAs are
shown in Table S3 in File S2.
Analysis of Eosinophil-related Molecules and Canonical
Pathways Potentially Regulated by the miRNAs
By using TargetScan (version 6.1), we identified consensus
mRNA targets of these 68 miRNAs. TargetScan is a search engine
for predicted targets of miRNA in eukaryotes. It searches for the
conserved and/or non-conserved 8- and 7-mer sites, which share
sequence homology with each miRNA, that are located in the 39-
UTR regions of mRNAs [48]. Predictions are then ranked by their
probability of targeting the mRNA transcript [49]. In this study,
the 95th percentile was used to predict the potential targets by
these 68 miRNAs with TargetScan. We identified 4988 mRNA
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transcripts that had the potential to be targeted by this group of
miRNAs (Fig. 5A). The target mRNAs were further refined by
searching the MeSH database, in an effort to link gene expression
data with known eosinophil-related pathways, diseases and
phenotypes. There were 1192 mRNAs identified by MeSH
database as containing the exact terms ‘‘eosinophils, eosinophilia,
IL-3, IL-5, eosinophil peroxidase, eosinophil cationic protein,
eosinophil granule proteins, eosinophil major basic protein or
eosinophil-derived neurotoxin’’ with a link to at least one
PubMed-affiliated reference. We then plotted differences in
distribution of mRNAs predicted by TargetScan and MeSH
databases, and found that, of the original 4988 transcripts, we
could identify 348 that were associated with eosinophil biology and
targeted by members of the 68 miRNAs that were identified by
both search methods (Fig. 5A and Table S4 in File S1).
To gain further understanding of the way in which the 348
eosinophil-associated mRNAs contribute to intracellular events in
eosinophils, these genes were then classified according to signaling
pathways using the IPA Ingenuity system; the top 30 canonical
pathways were listed (Fig. 5B; Table S5 in File S1). There are 140
molecules (40.2% of the 348 eosinophil-associated transcripts) that
are included within these top 30 canonical pathways. Although
many of the pathways are commonly involved in cell death and
survival or proinflammatory activity, these pathways may also
contribute to eosinophil differentiation and function. For example,
Glucocorticoid Receptor Signaling may contribute to eosinophil
Figure 1. Expansion of bmEos ex vivo. Bone marrow cells from BALB/c mice were cultured for 14 days, see Methods and samples taken from day
4 to day 14 in cultures grown in the presence of IL-5. Eosinophils were identified by (A) flow cytometry (SiglecF+Gr-12CD11b+CD11c2), (B) light
microscopy with Giemsa staining (1006) and (C) the percentages and numbers of bmEos were determined using a haemocytometer. Values are
presented as mean 6SEM (n= 4,6), **P,0.01 (d10, d12 or d14 vs. other groups). *P,0.05 (vs. d4, d6 or d8). # P,0.05 (vs. d4 or d6).
doi:10.1371/journal.pone.0097537.g001
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Figure 2. Expression levels of miRNA during bmEos differentiation. Bone marrow cells from BALB/c mice were cultured for 14 days. Heat
map representation of expression levels of miRNA that were up-regulated or down-regulated by more than 5-fold from day 4 to day14 in the
presence of IL-5. The fluorescence index of each miRNA at different timepoints was further normalized to that of the respective miRNAs in the control
group (isolated bone marrow cells). The normalized microarray data were managed and analyzed by GeneSpring (Agilent). Data represent three
independent bmEos cultures. Scale ranges from a signal value of26.1(blue) to 6.1(red). Some of miRNAs were selected to further confirm the efficacy
of miRNA array.
doi:10.1371/journal.pone.0097537.g002
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Figure 3. Confirmation of miRNA array expression by Taqman quantitative PCR. 8 miRNAs (miRNA -144, -223, -146a, -365, -155, -451, -194
and -494) were selected to verify the expression profile of the miRNA array. Samples were RNA isolated from cultured bone marrow cells from day 4
to day14 in the presence of IL-5, and represent three independent cultures. Values are presented as mean 6SEM (n= 4,6), **P,0.05 (vs. other
groups). *P,0.05 (vs. d4).
doi:10.1371/journal.pone.0097537.g003
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Figure 4. Expression of GATA -1/2, PU.1 and c/EBPe correlated with the expression levels of miRNAs that potentially target these
transcripts. Bone marrow cells were cultured as described in Methods and RNA samples were extracted from cells taken from day 4 to day14 which
had been grown in the presence of IL-5. A. Expression levels of GATA -1/2, PU.1 and c/EBPe were determined by qPCR. B. Potential miRNAs targeting
the 39-UTR of the four transcription factors were identified by TargetScan, the Miranda database and IPA ingenuity system. Blue represents decreased
MicroRNAs Regulate Eosinophilopoiesis
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viability [50] and PI3/AKT Signaling is critical for degranulation
[51]. Although evidence is limited, pathways such as IL-3, Insulin-
like growth factor 1 (IGF-1), IL-15, FLT3 Signaling in Hemato-
poietic Progenitor Cells, Erythropoietin and Role of JAK2 in
Hormone-like Cytokine Signaling pathways may serve to regulate
eosinophil differentiation and proliferation. The well-known
inflammatory pathways such as IL-6, Acute Phase Response,
Peroxisome Proliferator-Activated Receptor (PPAR), IL-12 and
Nuclear Factor- kB (NF- kB) likewise regulate the production of
proinflammatory factors by eosinophils. These cells may also use
Triggering Receptor Expressed on Myeloid Cells 1 (TREM1)
pathway to respond to infection, as TREM1 pathway is critical for
the regulation of acute inflammatory responses to microbial
products [52]. Interestingly, eosinophils may contribute to the
expression of miRNAs, whereas yellow is for increased expressed miRNAs. C. The fold changes of potential regulating miRNAs were calculated based
on the fluorescence index of each miRNA at different time-points, after normalization to that of the respective miRNAs in the control group (isolated
bone marrow cells). Data represent three independent eosinophil cell cultures. Values are presented as mean 6SEM (n= 4,6), **P,0.05 (vs. other
groups). *P,0.05 (vs. d4).
doi:10.1371/journal.pone.0097537.g004
Figure 5. Potential molecules and top canonical pathways that were predicted and targeted by the miRNAs that exhibited 5-fold
changes in expression. A. Target prediction by TargetScan database (http://www.targetscan.org/) was established on sequence data
complementarity to target 39UTR sites. Target molecules, associated with eosinophil biology, were identified by exact syntax matching in the
MeSH database. (http://www.nlm.nih.gov/MeSH/MeSHhome.html). B. Top 30 canonical pathways that consist of the putatively selected 348
molecules as identified by IPA. The significance of association between selected genes and canonical pathway was evaluated by a right-tailed Fisher’s
exact test to calculate a p value determining the probability that the association is not explained by chance alone (grey bars, upper y-axis). Ratios
referring to the proportion of selected genes from a pathway related to the total number of molecules that make up that particular pathway were
also displayed (line graph, bottom y-axis).
doi:10.1371/journal.pone.0097537.g005
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development of rheumatoid arthritis [53,54], as the three signaling
pathways, Role of Macrophages/Fibroblast and Endothelial Cell,
Altered T Cell and B Cell in Rheumatoid Arthritis and Role of
Macrophages/Fibroblast and Endothelial Cell in Rheumatoid
Arthritis, have been linked to pathogenesis of this disease.
Collectively, these data suggest important roles for miRNAs in
the regulation of both the biological function and cell death/
survival of bmEos.
Multiple miRNAs are Linked to the Expression of IL-5Ra
Chain and CCR3
As IL-5Ra, CCR3 and the secretory mediator, major basic
protein (MBP) are critical signature molecules for eosinophils, we
examined the expression of these factors in bmEos cultures from
day 4 to day 14 by qPCR (Fig. 6A). Relative expression of
transcripts encoding all three factors underwent significant
increases between day 4 and day 14, corresponding to the
profound increase in eosinophil number during this time period.
We used IPA software and the miRanda database to examine the
relationships between miRNAs and these specific transcripts, in
order to determine whether any of the 68 differentially expressed
miRNAs (Fig. 2) might have binding sequences that could target
their respective 39-UTRs. Interestingly, none of the aforemen-
tioned 68 miRNAs has any potential to regulate MBP or
eosinophil-associated ribonuclease (EAR) 1 and 2 (data not
shown). By contrast, IL-5Ra chain is linked to 7 miRNAs;
expression of 5 of these miRNAs undergoes a decrease (miR -7b, -
181c, -467e, -486 and -669b) and 2 (miR -362-5p and -1896) were
increased (Fig. 5B and C). CCR3 may be targeted by 10 miRNAs,
of which 7 (miR -7b, -378, -421, -467a, -467b, -467e and -486)
were decreased and 3 (miR -193b, -292-5p and -1896) were
increased (Fig. 6B and C). Moreover, four miRNAs (miR -7b, -
467e, -486 and -1896) may regulate the expression of both the IL-
5Ra chain and CCR3. The 39-UTR binding sites of these
miRNAs are included in Table S6 in File S2.
Association between miRNAs and Expression of Genes
Encoding Toll-like Receptors (TLRs) by bmEos
TLRs are vital innate immune receptors that detect and
respond to signals from infectious pathogens. Studies carried out
in vitro indicate that eosinophils express numerous TLRs [55–57].
We detected increased expression of transcripts encoding TLRs -4,
-6 and -13 between days 4 and 14, while transcripts encoding TLR
-1, -2, -3, -5, -7, -8, -9, -11 and -12 were decreased (Fig. 7A and
Fig. S1). By employing IPA software and miRanda databases, 10
miRNAs were directly associated with mRNA encoding TLR4, of
which 8 (miR -7b, -130a, -181c, -181d, -363, -374, -451 and -539)
were decreased and 2 (miR -135a and -200a) were increased (Fig. 7
B and C). TLR13 was associated with the decreased expression of
5 miRNAs (miR -125b-5p, -181c, -181d, -421 and -669f) and the
increased expression of 4 miRNAs (miR -28, -152, -546 and -1896;
Fig. 7B and C). Moreover, miR-181c and miR-181d have the
potential to regulate the expression of both TLR4 and TLR13. By
contrast, none of the aforementioned 68 miRNAs has the potential
to regulate the other TLRs. The 39-UTR binding sites of miRNAs
that target these mRNAs are shown in Table S7 in File S2.
Discussion
Our study was undertaken in order to examine miRNA
expression in bmEos during differentiation from a global
perspective starting within the cellular milieu of the BM, and
then to correlate miRNAs with expression of key eosinophil
signature transcripts in cultures enriched in differentiating
eosinophils. We have established ex vivo culture of bmEos and
determined the expression of characteristic receptors and
transcriptional regulators during their development. The miRNA
expression profile was determined and correlated to expression of
molecules known to be critical to eosinophil development by
stringent statistical and pathways analysis. With these approaches,
we report a unique miRNA network that is closely linked to
eosinophil differentiation programe.
Although mouse models are widely used to elucidate the
pathogenesis of human disease, their effectiveness towards
interpreting clinical observations remains a subject of debate
[58,59]. In particular, the differences between human and mouse
eosinophils are often used to explain the failure of mouse models to
reproduce important features of human allergic and parasitic
diseases. While it is true that significant differences between
human and mouse eosinophils exist [60], this does not necessarily
imply global and fundamental disparities in differentiation and
overall function [60]. Indeed, both species share similar signaling
mechanisms leading to the generation of terminally differentiated
eosinophils from committed progenitors [60]. For example, IL-3,
IL-5 and GM-CSF are eosinophilopoietic cytokines that critically
regulate the survival, expansion and differentiation of eosinophils
in both species [2,6,50]. The progenitors from both human and
mouse show a similar expression pattern of GATA family
transcription factors as well as other factors known to play key
roles in eosinophil differentiation, including PU.1 and c/EBP
proteins [24–26].
Eosinophil lineage progenitors are derived from hematopoietic
stem cells. Although it is recognized that a unique combinatorial
interaction of GATA -1 and -2, PU.1 and c/EBPe may provide
essential signals for the maturation [24–26], other factors may also
contribute to the differentiation. In this context, miRNAs provide
an additional but critical level of control by modulating mRNA
translation. Because miRNAs are not perfectly complementary to
their targets, each is capable of regulating a large number of
mRNAs. As such, miRNAs can potentially modulate entire
transcriptional programs, although key individual targets may
also be critically important [32–34]. Our results suggest that the
four key transcriptional factors are differentially targeted by
distinct groups of miRNAs (Fig. 4). To further validate the
relationships between miRNA and target mRNA, we cloned the
39UTR regions of GATA-1 into dual-fluorescence luciferase
reporter constructs (see Method S1). Co-transfection of luciferase
constructs with the mimics of the four miRNAs resulted in a dose-
dependent decreases in luciferase activity, compared to control
mimic, demonstrating that the four miRNAs directly target
GATA-1 transcript (Fig. S2). Notably, let-7e, miR-7b, -144 and
-130a, that were each ,100-fold decreased during eosinophil
hematopoiesis, are associated with the increased levels of transcript
encoding GATA-1, PU.1, GATA-1 and c/EBPe, respectively.
Notable, change of miR-130a was strongly correlated to that of c/
EBPe by Pearson correlation test (P,0.0005, r =20.97, Table S8
in File S1). In addition, miR -200a and -429 potentially regulate
multiple distinct transcription factors (Fig. 4B). Interestingly, these
two miRNAs belong to the same miR-200 family that play an
essential role in the suppression of tumors by inhibiting epithelial
mesenchymal transition [61], suggesting their roles (together with
other miRNAs) in controlling potential over-expression of the
targets and maintaining a fine balance between the four key
transcription factors.
Moreover, Lu et al (with C57BL/6 mice) have identified that
miR-21 regulates the development of eosinophils by modulating
the growth of eosinophil progenitors [62]. However, we could not
identify the significant changes of miR-21 in our list of miRNAs.
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Figure 6. Expression levels of IL-5Ra, CCR3 and MBP correlated with the expression of miRNAs that potentially target these
transcripts. Bone marrow cells were cultured as described in Methods and RNA samples were extracted from day 4 to day14 from cells grown in the
presence of IL-5. A. Expression levels of IL-5Ra, CCR3 and MBP were determined by qPCR. B. Potential miRNAs targeting the 39-UTR of IL-5Ra and
CCR3 were identified by TargetScan and MiRanda database and IPA ingenuity system. Blue represents decreased expression of miRNAs, whereas
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Considering that we used BALB/c background mice, we speculate
that the difference of the two studies is likely attributed to the
strain difference. Although miRNAs are highly conserved in
animals, the profiles of miRNA expression were previously found
to be significantly different across inbred mouse strains [63].
Furthermore, hematopoietic stem- and progenitor- cells exhibit
striking differences in genetic traits between mouse strains [64,65].
Recently, a study of mouse progenitor cells also indicates that
miRNA profiles are strain-dependent [66]. Nevertheless, Gerrits
et al have found an evolutionary conserved miRNA cluster
containing miR -99b, let-7e and miR-125a [66]. Notably, these
three miRNAs are highly expressed in the progenitor cells of
different mice strains but down-regulated during differentiation.
Similarly, we have also found that the expression of let-7e and
miR-125a were significantly decreased during eosinophil matura-
tion. By contrast to miR-99b, we have shown that miR-99a
expression was significantly reduced upon eosinophil differentia-
tion. Interestingly, both miR-99a and miR-99b belong to the same
miR-99 family which regulates cell proliferation by targeting Akt/
mTOR (mammalian target of rapamycin) signalling [67]. These
studies strongly support our observations and that of others in
terms of function and strain dependence.
Most recently, Bettigole et al showed that X-box binding protein
1 (XBP1) selectively determines eosinophil development, indepen-
dently from other known eosinophil-related transcription factors
including GATA-1 [28]. Interestingly, we have also demonstrated
that three miRNAs -(e.g. miR -125a-3p, -196a and -196b)- with
decreased profiles may also target XBP1 transcripts, although we
didn’t detect altered expression of XBP1 during bmEos differen-
tiation (data not shown). These results suggest that the aforemen-
tioned miRNAs may control the translation of their target instead
of degrading XBP1 transcript and, as such, they represent a
distinct network in control of eosinophil maturation.
To investigate further the connectivity of miRNAs and other
intracellular signaling pathways, we generated a list of 348
potential mRNAs that associated with eosinophil biology and
are targeted by the miRNAs, by cross-comparison with TargetS-
can and MeSH database. With IPA Ingenuity system, we further
showed that 40.2% of miRNAs-targeted mRNAs were included
within the top 30 canonical signaling pathways, among which
were molecules controlling cell cycle, growth and death, and cell
activation (Fig. 5). For example, PTEN signaling and PI3K/AKT
signaling are closely paired, and serve to balance one another in
order to regulate cell proliferation. Impairment of PTEN signaling
may lead to PI3K/AKT hyperreactivity, resulting reduced
apoptosis and unchecked cell proliferation [68]. Furthermore,
miRNA may also target other pathways such as IL-3, IGF-1, IL-15
and FLT3 signaling that may contribute to the early eosinophil
progenitor commitment. Interestingly, miRNAs are associated
with HMGB1 pathway, indicating that miRNAs indirectly
regulate chromatin remodelling. In addition, inflammatory
pathways such as IL-6, IL-12, JAK/STAT and NF-kB signalings
may be closely modulated by miRNAs.
Interestingly, among the 348 potential miRNA targets, IL-5Ra
and CCR3 are well-known signature receptors of eosinophils
[2,4,5]. The expression of IL-5Ra and CCR3 were increased
almost 250-fold and 180-fold respectively, from day 4 to day 14 of
culture (Fig. 6A). These results are consistent with the expansion of
the SiglecF+Gr-1+CD11b+CD11c2 bmEos population. Although
MBP transcripts were also increased about 100-fold, none of 68
miRNAs identified here are known to target this molecule.
Furthermore, none of these miRNAs are associated with EAR 1
and 2 transcripts encoding the eosinophil associated ribonucleases,
which are the mouse orthologs of eosinophil cationic protein (ECP)
and eosinophil-derived neurotoxin (EDN). Interestingly, four
miRNAs (miR -7b, -467e, -486 and -1896) were closely associated
with the expression of both IL-5Ra and CCR3. Moreover, several
miRNAs (e.g. miR -193b, -292-5p, -362-5p, -467a -467b, -467e
and -486 -1896) recognize the multiple sites in the IL-5Ra and/or
CCR3 39-UTR (Table S6 in File S2). Among these miRNAs, the
expressions of four miRNAs (miR-7b (P,0.05, r =20.7617); miR-
181c (P,0.05, r =20.7719); miR-467e (P,0.05, r =20.826) and
miR-669b (P,0.05, r =20.8171)) were negatively correlated to
the expression of IL-5Ra by Pearson correlation test (Table S8 in
File S1).
Eosinophils interact with the environment via releasing their
granule contents including MBP, ECP and EDN [2]. Recent
findings suggest that eosinophils interact with bacteria by
producing neutrophil-extracellar traps (NETs) structures com-
posed of mitochondrial DNA, MBP and ECP [69]. Indeed,
stimulation of eosinophils with lipopolysaccharide (LPS) promotes
the cells to produce tumor necrosis factor a and eosinophil cationic
protein in a dose-dependent manner. Likewise, studies carried out
in vivo suggest that activation of TLR7/MyD88 is essential for
eosinophil-mediated clearance of virion challenge [57]. However,
how eosinophils specifically recognize infectious targets remains
uncertain. In this context, TLRs are among the most important
pattern recognition receptors and they may act as infection sensors
for eosinophils [55–57]. Indeed, there are reports showing that
human eosinophils constitutively express TLR transcripts (e.g.
TLR -1, -4, -7, -9 and -10), and mouse eosinophils can express
both surface and intracellular TLR receptors (TLR -3, -4 and -7)
[56,57]. To determine if any of the 68 miRNAs are linked to
TLRs, we first determined the expression levels of all twelve mouse
TLRs and found that three TLRs (TLR4, TLR6 and TLR13) are
increased while those encoding the remaining TLRs decrease
during bmEos differentiation (Fig. 7). TLR13 is newly identified as
a molecular sensor for bacterial 23S rRNA [70]. TLR13 is an
intracellular receptor, belonging to TLR11 family [71]. Currently,
it is believed that intracellular TLRs recognize nucleic acid sensors
[72], suggesting a likely role of TLR13 in anti-viral infections.
There is no identified human ortholog of this receptor. It is
interesting to note that the TLR13 transcript is identified in
eosinophils; whether these cells employ TLR13 to regulate anti-
bacterial infection requires further studies. In order to explore the
connections between miRNAs and TLR expression in bmEos, we
identified that two distinct sets of miRNA are likely involved in the
expression of TLR4 and TLR13 transcripts (Fig. 7 and Table S7
in File S2). Among these miRNAs, miR-181c shows profound links
to TLR4, TLR13 and IL-5Ra; miR-7b also shows the extensive
association with major eosinophil factors including TLR4, PU.1,
IL-5Ra and CCR3. MiR-669f, with decreased expression, is
related to the increased transcripts of both PU.1 and TLR13.
These miRNAs with down-regulated profiles are paralleled with
their up-regulated targets, suggesting that they may play greater
roles in the regulation of eosinophil biology.
Hitherto, there is very limited experimental evidence available
for the biological roles of the identified miRNA networks.
yellow is for miRNAs with increased expression. C. The fold changes of potential regulating miRNAs were calculated based on the fluorescence index
of each miRNA at different time-points, after normalization to that of the respective miRNAs in the control group (isolated bone marrow cells). Data
represent three independent eosinophil cell cultures. Values are presented as mean 6SEM (n= 4,6), **P,0.001 (vs. other groups). *P,0.01 (vs. BM).
doi:10.1371/journal.pone.0097537.g006
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Figure 7. Expression of TLR4, TLR6 and TLR13 correlated with the expression of miRNAs that potentially target these transcripts.
Bone marrow cells were cultured as described in Methods and RNA samples were extracted from day 4 to day14 from cells grown in the presence of
IL-5. A. Expression levels of TLR4, TLR6 and TLR13 were determined by qPCR. B. Potential miRNAs targeting the 39-UTR of TLR4, TLR6 and TLR13 were
identified by TargetScan, the MiRanda database and IPA ingenuity system. Blue represents decreased expression of miRNAs, whereas yellow is for
miRNAs with increased expression. C. The fold changes of potential regulating miRNAs were calculated based on the fluorescence index of each
miRNA at different time-points, after normalization to that of the respective miRNAs in the control group (isolated bone marrow cells). Data represent
three independent eosinophil cell cultures. Values are presented as mean 6SEM (n= 4,6), **P,0.001 (vs. d4, d6, d8 or d10).
doi:10.1371/journal.pone.0097537.g007
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However, emerging studies show the unique roles of several of
miRNAs in controlling cell growth and differentiation and it is
likely that these miRNAs, forming networks, may influence the
process of eosinophilopoiesis via the post-transcriptional regula-
tion. For example, miRNA cluster including let-7e and miR-125a
is implicated in hematopoiesis [66]; miR-7b inhibits proliferation
of mouse pancreatic b cells [73]; miR-144 together with miR-451
controls erythropoiesis [39]; miR-130a plays key roles in
regulating angiogenesis, tumor development and inflammatory
disease and also anti-viral responses [74–77]. Furthermore, miR-
196a has been shown to regulate stem cell proliferation, fibroblast
function, angiogenesis and tumor cell growth [78–81].
In conclusion, we have utilized a model of bmEos differenti-
ation, which has enabled examination of the expression patterns of
miRNAs during eosinophil development. We have analysed these
patterns, and have identified miRNAs that may play pivotal roles
in driving bmEos maturation and regulating eosinophil anti-
infection function. These selected miRNAs can be grouped as
networks in order to guide bone marrow cells toward bmEos
development in cooperation with cytokine signaling. Furthermore,
there are also key intracellular signaling pathways that may be
regulated by these miRNAs. To understand how these selected
miRNAs interact with their targets, further functional studies with
miRNA targeting are required and we will proceed with knock-in
and knock-down models. Manipulating the expression of these
miRNAs may promote understanding of the underlying mecha-
nisms that are critical for eosinophil biology and ultimately provide
therapeutic benefits for treating eosinophil-associated diseases.
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Figure S1 Expression of TLR1, TLR2, TLR3, TLR5,
TLR7, TLR8, TLR9, TLR11 and TLR12 correlated with
the expression of miRNAs that potentially target these
transcripts. Bone marrow cells were cultured as described in the
Methods and RNA samples were extracted from day 4 to day14
from cells grown in the presence of IL-5. Expression levels of the
above TLRs were determined by qPCR. Data represent three
independent eosinophil cell cultures. Values are presented as mean
6SEM (n= 4,6), *P,0.01 (vs. d4).
(TIF)
Figure S2 Luciferase activity in lysates of HEK293 cells
transfected with constructs encoding the 39UTR region
of GATA-1 and miRNA mimics (miR-378, let-73, miR-
200a and miR-429) or scrambled control mimic at the
concentrations indicated. Ctrl = control. n = 6, values repre-
sented as mean6SEM. At respective concentration, *P,0.05,
miR-378 mimic v.s. Ctrl mimic; **P,0.05, let-7e mimic v.s. Ctrl
mimic treatment; # P,0.05, let-7e mimic v.s. Ctrl mimic; w P,
0.05, let-7e mimic treatment v.s. Ctrl mimic.
(TIF)
Table S1 Primer sequence for determining mRNA
levels by quantitative PCR.
(DOC)
File S1 This file includes: Table S2. Annotation of
miRNAs with greater than 5 fold changes, as shown in
Figure 2; Table S4. Eosinophil related canonical path-
ways potentially regulated by the miRNAs; Table S5.
Eosinophil related canonical pathways potentially regu-
lated by the miRNAs; and Table S9. Pearson correlation
test of the miRNAs and their targets.
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sites between GATA1, PU.1 and their respective miR-
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Potential binding sites between TLR4, TLR13 and their
respective miRNAs.
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